Table S1 : Antibiotic treatment of mechanically ventilated patients prior to sampling. Isolates were obtained from ET biofilms (ET), throat swabs (TS), nose swabs (NS) and sputum samples (SS). S: sensitive towards an antimicrobial substance; I: intermediately resistant; R: resistant. 1: Resistance was determined by investigating susceptibility towards oxacillin. 2: Resistance was determined by investigating susceptibility towards ciprofloxacin. 3: Resistance was determined by investigating susceptibility towards meropenem. 4: Resistance was determined by investigating susceptibility towards flucanozole. 5: Resistance was determined by investigating susceptibility towards tobramycin. 6: Resistance was determined by investigating susceptibility towards vancomycin. Patient Antibiotic class ET TS NS SS 1 Cefazolin, cefuroxime1 R Levofloxacin2 I 2 Levofloxacin S S 3 Cefazolin, cefuroxime S R S R Levofloxacin S S S 4 Meropenem3 S S S 5 Meropenem S I S Fluconazole4 R R Amikacin5 S S S Teicoplanin6 S S S S 7 Cefuroxime R S S Teicoplanin S S S 9 Meropenem S 10 Cefuroxime R R S R Teicoplanin S S S S Fluconazole S 12 Fluconazole S 15 Ciprofloxacin, I I Moxifloxacin 16 Cefuroxime S R R Levofloxacin R 17 Ceftazidime, Cefuroxime S S S Ciprofloxacin R I 18 Vancomycin S S S Ceftazidime, Cefotaxime S R S 19 Meropenem S S
Table S1 : Antibiotic treatment of mechanically ventilated patients prior to sampling. Isolates were obtained from ET biofilms (ET), throat swabs (TS), nose swabs (NS) and sputum samples (SS). S: sensitive towards an antimicrobial substance; I: intermediately resistant; R: resistant. 1: Resistance was determined by investigating susceptibility towards oxacillin. 2: Resistance was determined by investigating susceptibility towards ciprofloxacin. 3: Resistance was determined by investigating susceptibility towards meropenem. 4: Resistance was determined by investigating susceptibility towards flucanozole. 5: Resistance was determined by investigating susceptibility towards tobramycin. 6: Resistance was determined by investigating susceptibility towards vancomycin. Patient Antibiotic class ET TS NS SS 1 Cefazolin, cefuroxime1 Levofloxacin2 I R 2 Levofloxacin S S 3 Cefazolin, cefuroxime Levofloxacin S R S S S R S 4 Meropenem3 S S S 5 Meropenem Fluconazole4 Amikacin5 Teicoplanin6 S R S S I R S S S S S S 7 Cefuroxime Teicoplanin R S S S S S 9 Meropenem S 10 Cefuroxime Teicoplanin Fluconazole R S S R S S S R S 12 Fluconazole S 15 Ciprofloxacin, Moxifloxacin I I 16 Cefuroxime Levofloxacin S R R R 17 Ceftazidime, Cefuroxime Ciprofloxacin S R S I S 18 Vancomycin Ceftazidime, Cefotaxime S S S R S S 19 Meropenem S S
4214673.docx